CONTENTS:
- A conversation about recovery and political activism [Editorial]. Zigon J., Vitellone N., Duff C., Theodoropoulou L., art. 103614.
- New temperance movements across the cinemas of Canada [Editorial]. Szymanski A., art. 103651.
- Practising recovery: New approaches and directions [Editorial]. Theodoropoulou L., Vitellone N., Duff C., art. 103802.
- The particularity of freedom and recovery from addiction in practice: On the therapeutic limitations of generalising addiction science. Weinberg D., art. 103609.
- Recovery as a minor practice. Vitellone N., Theodoropoulou L., Manchot M., art. 103618.
- The line of vulnerability in a recovery assemblage. Sultan A., Duff C., art. 103740.
- Opioid prescribing restrictions and opioid use among the Louisiana Medicaid population. Callison K., Karletsos D., Walker B., art. 103770.
- Exhausted practical sovereignty and lateral agency: Non-uptake of treatment for hepatitis C in the antiviral era. Fraser S., Moore D., Farrugia A., Fomiatti R., Edwards M., Birbilis E., et al., art. 103771.
- The potential of mind wandering in the recovery from addiction. Ledésert C., art. 103772.
- Navigating opioid agonist therapy among young people who use illicit opioids in Vancouver, Canada. Pilarinos A., Kwa Y., Joe R., Thulien M., Buxton J.A., DeBeck K., et al., art. 103773.
- Testosterone vs. steroids: Comparing the disciplined bodywork projects of performance and image enhancing drug users in Australia. James E., Wynn L.L., art. 103776.
- Drug checking use and interest among people who inject drugs in Toronto, Canada. Rammohan I., Bouck Z., Fusigboye S., Bowles J., McDonald K., Maghsoudi N., et al., art. 103781.
- A rapid assessment of take-home naloxone provision during COVID-19 in Europe. McDonald R., Eide D., Abel-Ollo K., Barnsdale L., Carter B., Clausen T., et al., art. 103787.
- Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot. Treloar C., Lancaster K., Gendera S., Rhodes T., Shahbazi J., Byrne M., et al., art. 103788.
- Stakeholder views of current laws surrounding alcohol at UK football matches: Is it a case of using a "sledgehammer to crack a nut"? Martin J.G., Giulianotti R., Bandura C., Morrow S., Hunt K., Bancroft A., et al., art. 103789.
- Behavioral patterns of people who use synthetic psychostimulants: Results of a qualitative study in St. Petersburg, Russia. Skochilov R., Aserova E., Lakhov A., Antonova D., ?ulikova I., Shagina A., et al., art. 103790.
- The practice and embodiment of "goofballs": A qualitative study exploring the co-injection of methamphetamines and opioids. Ivsins A., Fleming T., Barker A., Mansoor M., Thakarar K., Sue K., et al., art. 103791.
- Drug use behaviors, trauma, and emotional affect following the overdose of a social network member: A qualitative investigation. Macmadu A., Frueh L., Collins A.B., Newman R., Barnett N.P., Rich J.D., et al., art. 103792.
- The alcohol prevention magnitude measure: Application of a Spanish-language version in Santiago, Chile. Contreras L., Libuy N., Guajardo V., Ibanez C., Donoso P., Mundt A.P., art. 103793.
- Systems mapping to understand complexity in the association between image and performance enhancing drugs (IPEDs) and harm. Bates G., Ralphs R., Bond V.W., Boardley I., Hope V., Van Hout M.-C., et al., art. 103801.